Abstract
Background The COVID-19 pandemic presented healthcare workers and public health agency a unique challenge of having to rapidly deliver a novel set of vaccines during a public health crisis. For pediatric patients, there was an additional layer of complexity given the delayed timeline to deliver these vaccines and the differences in dosing and available products depending on the age of those receiving the vaccine. This paper investigates the spatial accessibility and uptake of the COVID-19 vaccine in King County, WA, USA.
Methods Public data for COVID-19 vaccine sites to calculate spatial accessibility using an enhanced two step floating catchment area (E2SFCA) technique. Spatial regression analyses were done looking at the relationship between spatial accessibility and ZIP code level vaccination rates. Relationships with other socioeconomic and demographic variables were calculated as well.
Findings Higher rates of vaccine accessibility and vaccine coverage were found in adolescent (12 to 17-year-old) individuals relative to school age (5 to 11-year-old) individuals. Vaccine accessibility was positively associated with coverage in both age groups in the univariable analysis. This relationship was affected by neighborhood educational attainment.
Interpretation This paper successfully demonstrates how spatial accessibility measures such as E2SFCA can be used to assess the availability of the COVID-19 vaccine in a region such as a metropolitan area or county. It also provides insight into some of the ecological factors that affect COVID-19 vaccination rates. Implementation of these technique could help public health authorities and healthcare organization plan future vaccination efforts.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no specific funding source involved in the design, analysis, or writing of this paper.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Current vaccine locations can be found using the Vaccinate WA website at: https://vaccinelocator.doh.wa.gov/?language=en and updated vaccine coverage data can be found using the Public Health Seattle & King County website at: https://kingcounty.gov/en/legacy/depts/health/covid-19/data/vaccination.aspx. These websites do not archive previous data. The specific datasets used in the analysis can be obtained at request of the authors and will be uploaded to a code repository once the paper is fully published.
